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M
agnetic resonance spectroscopy (MRS) is a
companion technique to the more familiar
magnetic resonance imaging (MRI) scan.
Whereas MRI determines the spatial distribu-
tion of water (and lipid) protons across a region of interest,
MRS measures the chemical content of MR-visible nuclei,
which include the metabolically relevant elements of
hydrogen (
1H), carbon (
13C), and phosphorus (
31P). MRS is
particularly advantageous for assessing metabolism be-
cause the chemical properties and environment of each
nucleus determine the frequency at which it appears in the
MR spectrum, giving rise to peaks corresponding not only
to speciﬁc metabolites but also to the constituent nuclei
of each metabolite (Fig. 1). It is therefore a multimodal,
noninvasive technique capable of measuring a broad range
of biological compounds across a variety of tissues. Re-
peated measures of metabolite content, metabolic ﬂuxes,
and their response to an intervention are possible, char-
acteristics that make MRS ideally suited for in vivo studies
of human metabolism. An additional advantage is that MRI
scans can be obtained concurrently to provide structural/
anatomical information that can guide data acquisition and
assist in data analysis and interpretation. In this review, we
will highlight some of the applications by which MRS can
be used to investigate metabolism, focusing on its appli-
cation to in vivo human studies.
METHODOLOGICAL CONSIDERATIONS FOR IN VIVO
STUDIES
The versatility of MRS provides a hugely ﬂexible technique
capable of probing a broad range of metabolic applications
across a variety of tissues. Despite its many advantages,
particularly for studies of human metabolism where non-
invasive techniques are at a premium, effective imple-
mentation of MRS in vivo requires consideration of its
methodological limitations and how they inﬂuence its
application in speciﬁc organs. In many instances, these
issues can be overcome by the methodological setup and
a judicious choice of the pulse sequence used to excite and
detect the MR signal.
As an analytical technique, MR is relatively insensitive
compared with other modalities, and tissue metabolite
concentrations in the millimolar range are required, gen-
erally, to be detectable in vivo. The low natural abundance
of some MR-visible isotopes (e.g.,
13C is only 1.1% of total
carbon) may further compromise detection, resulting in
long scan times. Maximum sensitivity can be achieved by
using an appropriate radiofrequency (RF) coil for signal
detection, optimized for the nucleus of interest. Reso-
nances of highly abundant compounds will dominate the
spectrum and may obscure or distort peaks of interest.




13C spectra of muscle and liver fea-
ture prominent lipid peaks. Because numerous peaks are
observed in
1Ha n d
13C spectra, spurious signals of other
species, or unwanted signal inﬁltration from surrounding
tissues (e.g., subcutaneous fat, the scalp), may overlap
peaks of interest and impair the ability to resolve or quantify
a particular metabolite.
Pulse sequences are available that suppress speciﬁc
peaks (e.g., water suppression) (Fig. 2), that excite only
resonances of interest, or that conﬁne the MR signal to a
speciﬁc volume (voxel), creating a localized spectrum (Fig. 3).
Spectra can also be simpliﬁed by removing (“decou-
pling”) the dipolar coupling interaction between adjacent
nuclei (e.g.,
13C bonded to
1H), which causes peak splitting, or
by spectral “editing” to selectively enhance the signal from
the metabolite(s) of interest. Typically, several of these
options are combined to generate the best quality in vivo
spectrum.
The MR properties of a compound or tissue may also
modulate the extent to which a metabolite is visible or
resolvable in vivo. Large proteins and macromolecules
give rise to broad, nonspeciﬁc signals (visible as baseline
distortions in brain
1H spectra), and metabolite signals
from liver and adipose tissue are signiﬁcantly broader than
those from muscle and brain because of the shorter T2
relaxation times in these tissues. Spectral resolution is also
compromised by effects that perturb the homogeneity of
the local magnetic ﬁeld within the region of interest; this is
particularly apparent at air-tissue-bone interfaces (e.g., the
sinuses), which exhibit differences in magnetic suscepti-
bility. Resolution can be enhanced by correcting local ﬁeld
inhomogeneities by applying additional external magnetic-
ﬁeld gradients across the region of interest (“shimming”).
All MR techniques are susceptible to artifacts induced
by motion, whether a result of inadvertent movement of
the subject, respiration, the cardiac cycle, or skeletal
muscle contractions. These include the inﬁltration of un-
wanted regions into the volume of interest (e.g., the gall
bladder during liver MRS), compromised voxel selection,
and the blurring of spectral resolution. Breath hold is
a common strategy during torso and abdominal MRI, but
the longer acquisition times associated with MRS favor
respiratory gating, typically at end expiration when chest
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PERSPECTIVES IN DIABETESmovement is minimal. MRS of the heart is typically ac-
complished with combined heart-rate and respiratory gat-
ing to compensate for both cardiac and respiratory motion.
Although gating increases the experimental duration, the
improvement in spectral quality is signiﬁcant. Blood also is
a major contaminant for cardiac MRS, and techniques have
been developed to remove or correct for signal inﬁltration
or artifacts induced by blood ﬂow.
A detailed analysis of MRS pulse sequences, hardware,
and techniques is beyond the scope of this review, but
thorough descriptions can be found in the excellent book
by de Graaf (1).
IN VIVO MRS STUDIES OF HUMAN METABOLISM
In vivo studies of human metabolism can be loosely
grouped into four categories: 1) static estimates of me-
tabolite content (e.g., to examine a particular subject
population or the effects of an intervention); 2) dynamic
monitoring of metabolites to investigate the effects of
an intervention (e.g., exercise, insulin stimulation) in real
time; 3) calculation of unidirectional metabolic ﬂuxes of
equilibrium exchange reactions by magnetization transfer
techniques; and 4) estimation of metabolic reaction rates
using MR-visible tracer kinetics. The following section
will give a broad overview of the application of these
techniques to investigate human metabolism in vivo.
Static measures of metabolite content. The most widely
implemented in vivo MRS technique is the use of localized
1H spectroscopy to estimate lipid content. In muscle,
intramyocellular lipid (IMCL) and extramyocellular lipid
(EMCL) peaks can be resolved (Fig. 3) as a result of slight
differences in chemical shift between each compartment,
an effect dependent on the relative orientation of the
muscle ﬁbers with respect to the ﬁeld of the MR scanner
(2). As a result of variations in composition, lipid content
typically is expressed relative to the water or creatine peak
used as internal standards. Extending initial ﬁndings in
muscle biopsy studies, IMCL content was observed to be
inversely correlated with insulin sensitivity in lean, healthy
individuals (3) as well as in obese and type 2 diabetic
subjects (4–6), suggesting a role for the accumulation of
lipid in the mechanism of insulin resistance (7,8). A notable
exception occurs in endurance-trained athletes, who have
increased IMCL content despite remaining highly insu-
lin sensitive (6), although this apparent paradox may be
explained by enhanced conversion of detrimental lipid
intermediates (e.g., diacyglycerol, ceramides) to triglyceride
(TG) (9,10).
Analogous
1H-MRS techniques can measure intrahepatic
lipid (IHL), which has similarly been correlated with liver
insulin resistance (8,11,12). Interventions that decrease
IHL, including drug treatment (12–14) and diet and exer-
cise (15–17), signiﬁcantly improve hepatic insulin sensi-
tivity. These methods are the ﬁrst MRS techniques to
achieve widespread implementation because data acqui-
sition and analysis are relatively rapid (,1 h to measure
both IMCL and IHL) and can be performed on clinical MR
scanners. Our group now includes
1H-MRS lipid measure-
ments as a screening tool to help identify insulin-resistant
individuals, and the techniques are also being used as
a biomarker to assess the efﬁcacy of lifestyle intervention
in the TuLIP (Tuebingen Lifestyle Intervention Programme)
trial (15,18). MRS estimates of IHL also have become the
gold standard for the diagnosis of nonalcoholic fatty liver
FIG. 1. MRS measures the chemical content of MR-visible nuclei across
a region of interest and provides positional information as well as
content. The
13C-MRS spectrum of glutamate displays peaks corre-
sponding to each carbon atom of the molecule.
FIG. 2. In vivo MR spectra are dominated by signals from highly abun-
dant metabolites. A: The
1H spectrum of the brain features a prominent
water peak that overwhelms the metabolite signals. Pulse sequences
are available that selectively suppress or excite speciﬁc frequencies.
B: The inclusion of a water-suppression module selectively minimizes
the
1H2O peak and enhances the detection of brain metabolites. tCr,
creatine-CH3.
FIG. 3. A localized muscle
1H spectrum acquired from a speciﬁcr e g i o n
(voxel) within the soleus muscle. A: The selected voxel is outlined by
a white box superimposed on a cross-sectional MRI image of the calf.
B: Multiple lipid peaks can be resolved enabling the quantiﬁcation of IMCL
and EMCL. Peak 1: water; peak 2: choline-CH3; peak 3: creatine-CH3; peak
4: EMCL-CH2; peak 5: IMCL-CH2; peak 6: EMCL-CH3; and peak 7: IMCL-
CH3.
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ethnic differences in the prevalence of fatty liver (19,20).
The presence of myocardial TG also can be observed
using cardiac and respiratory-gated localized
1H-MRS (21).
Their accumulation has been correlated with BMI (22) and
impaired glucose tolerance, occurring prior to the onset of
overt type 2 diabetes or left ventricular systolic dysfunc-
tion (23).
The bioenergetic state of a tissue can be characterized
by using
31P-MRS to estimate the concentrations of high-
energy phosphate (HEP) compounds or, more typically,
their ratios. Unlike biochemical assays, only metabolically
active (unbound) molecules are measured. Gross differ-
ences in muscle ﬁber–type composition can be distin-
guished on the basis of HEP ratios (24), and abnormalities
also are observed in dystrophic muscle (25). The phos-
phocreatine (PCr)-to-ATP ratio is decreased in many
cardiac disorders, including dilated cardiomyopathy, left
ventricular hypertrophy, coronary artery disease, and heart
failure, as well as infarcted heart (26–28). Bioenergetic
deﬁcits may predict clinical severity (27,29,30) and are ac-
companied by decreased creatine content, determined by
1H-MRS (31), which also characterizes nonviable post-
ischemic myocardium (32). Despite normal left ventricular
morphology, mass, and systolic function, diabetic heart
exhibits a decreased PCr-to-ATP ratio, which is associated
with underlying diastolic dysfunction (33). Hepatic HEPs
also can be measured, and decreases in ATP and inorganic
phosphate (Pi) have been observed in nonalcoholic steato-
hepatitis (34) and type 2 diabetes (35), suggesting that
impairments in liver energetics may be associated with the
development of steatosis. Phosphoesters are detected in
hepatic
31P spectra, and alterations in phosphomonester
and phosphodiester content have been observed in diffuse
liver disease (36). Increases in the phosphomonester-to-
phosphodiester ratio may be correlated with the severity
of disease (37,38), enabling
31P-MRS to offer an alternative
to histopathology for assessing progression from steatosis
to ﬁbrosis to cirrhosis and hepatitis.
Edited and nonedited
1H-MRS techniques also have been
used to observe the effects of cerebral disease on brain
metabolite content. Lactate content is elevated in infarcted
regions following a stroke, whereas the neurologic marker
N-acetyl aspartate (NAA) is decreased (39). Decreases in
NAA have been detected in epileptogenic regions of the
brain, with colocalized derangements in HEP content, sug-
gesting that mitochondrial loss and a bioenergetic deﬁcit
may be a contributing factor (40). The inhibitory neuro-
transmitter, g-aminobutyric acid (GABA), also is decreased
in epileptic subjects and can be restored by Vigabatrin
treatment (41), accompanied by a reduction in seizure
occurrence (42).
Dynamic metabolic MRS. The classic dynamic MRS ex-
periment is to monitor the bioenergetic response of
31P
metabolites to a sustained muscle contraction or exercise.
To maintain the intracellular ATP concentration during
this increased energy demand, PCr is depleted, Pi accu-
mulates, and intracellular pH may also be modulated as
a result of anaerobic glycolysis (Fig. 4). Although the in-
tracellular concentration of free (unbound) ADP is too low
to be observed directly with
31P-MRS, it can be calculated
indirectly, assuming equilibrium at creatine kinase (CK).
Upon cessation of exercise, each metabolite recovers to
baseline levels. With relatively rapid (,~8 s) time resolu-
tion and certain assumptions, a range of bioenergetic
ﬂuxes can be determined from the metabolite changes,
including the CK ﬂux and glycolytic and oxidative con-
tributions to ATP production. A functional estimate of
mitochondrial oxidative capacity can be calculated from
the kinetics of PCr recovery. A detailed analysis of these
methods is beyond the scope of this article, but several
comprehensive reviews are available in the literature (43).
Several studies have investigated the energetic response
of muscle to different workloads and conditions to ex-
amine the regulation of muscle energy production dur-
ing exercise. Signiﬁcantly, these studies have illustrated
that PCr recovery kinetics are dependent not only on the
end-exercise concentrations of PCr and ADP but also on
pH (44). Therefore, to estimate mitochondrial capacity
accurately, particularly when assessing populations with
impaired muscle bioenergetics, these factors must be con-
sidered and controlled. MRS studies have demonstrated
FIG. 4. A: Dynamic
31P-MRS data acquired during muscle contraction and recovery (data courtesy of J. Kent-Braun). B: To maintain cellular ATP
concentrations (dashed line) during the contraction, PCr (solid line) is depleted because of the CK reaction and Pi (dotted line) accumulates.
Intracellular pH, calculated from the chemical shift separation between the PCr and Pi peaks, increases initially as a result of PCr hydrolysis; H+
production attributed to anaerobic glycolysis may cause intracellular acidiﬁcation during longer contraction protocols. PCr, Pi, and pH recover to
baseline upon cessation of the contraction.
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training, consistent with mitochondrial biogenesis and
enhanced aerobic performance, and that the metabolic
perturbations associated with exercise are attenuated (45).
The metabolic economy of muscle contraction during ex-
ercise has been found to decrease as intensity increases
(46). During a ramped exercise protocol, elderly subjects
exhibit less muscle acidiﬁcation and are more resistant to
fatigue (47), potentially as a result of less reliance on gly-
colytic ATP production and an undiminished mitochon-
drial oxidative capacity (48). Bioenergetic insufﬁciencies
in muscle also have been observed in patients with car-
diovascular disease (49,50), chronic fatigue (51), and type
2 diabetes (52). Dynamic
31P-MRS may emerge as a clinical
test for the early diagnosis of ischemic heart disease be-
cause abnormal cardiac energetics are observed in re-
sponse to a handgrip exercise stress test (53,54), an effect
that is apparent in the absence of angiographically signif-
icant coronary stenoses (55).
Myocellular oxygenation can be assessed using
1H-MRS to
monitor the appearance of deoxymyoglobin (oxymyoglobin
is effectively undetectable) when a mismatch occurs be-
tween oxygen demand and supply (56) (e.g., during exer-
cise or ischemia). The appearance of deoxymyoglobin in
exercising muscle is approximately proportional to the
workload at low to intermediate intensities and then reaches
a plateau (57). Intracellular oxygenation is dependent on
contraction frequency as well as intensity (58), and perfusion
insufﬁciencies can be detected in peripheral artery disease
(59). Lactate production in exercising muscle, attributed
to anaerobic glycolysis, can be indirectly estimated from
rates of intracellular acidiﬁcation. Direct measurements of
lactate using edited
1H-MRS are possible in muscle (60,61),
although they remain to be fully validated. In contrast,
transient increases in brain lactate during photic stimu-
lation can be directly observed using
1H-MRS because of
the lack of overlapping lipid peaks (62).
Intramuscular glycogen stores can be detected with
13C-MRS and are depleted by longer-duration exercise (63);
repletion occurs via insulin-dependent and independent
mechanisms (63) and is inﬂuenced by diet (64). IMCL
utilization also may occur, dependent on exercise duration
and workload (65). The transition between the fed and
fasting states has also been investigated using MRS tech-
niques. During short-term fasting, liver glycogen is depleted
(66), followed at longer durations (.72 h) by signiﬁcant
accumulation of IMCL (67) and IHL (68), which is likely
driven by the increase in circulating plasma fatty acid
concentrations. Postprandially, glycogen is replenished
in muscle and liver (69) by both direct and indirect path-
ways of glycogen synthesis (70,71). Using a combination of
MRS and non-MRS techniques, the contribution of hepatic
gluconeogenesis to endogenous glucose production was
estimated to be ~50%, even during the earliest time points of
a fast, which is signiﬁcantly higher than expected (66,72). In
type 2 diabetes, elevated rates of fasting endogenous glu-
cose production were found to be caused by increased
gluconeogenesis rather than net hepatic glycogenolysis (73).
Magnetization-transfer techniques. The unidirectional
ﬂuxes that contribute to metabolic exchange reactions can
be examined using magnetization-transfer (MT) techni-
ques. The underlying concept of these methods is that if
the MR signal of a metabolite is perturbed, the transfer of
this effect to its exchange partner can be detected, with
the magnitude of the MT effect proportional to the kinetics
of exchange (Fig. 5). Unidirectional metabolic ﬂuxes can
then be calculated using classical reaction kinetics. Bio-
energetic rates can therefore be investigated using
31P-MT
spectroscopy. Decreased CK (PCr → ATP) ﬂux is observed
in congestive heart failure (74) and left ventricular hyper-
trophy (75), suggesting that myocardial ATP generation
is impaired in the pathophysiology of human heart dis-
ease. Rates of Pi → ATP ﬂux have been estimated in
resting muscle and were observed to be decreased in
insulin-resistant elderly individuals (76) and insulin-
resistant offspring of type 2 diabetic patients (77), in-
dicating a bioenergetic deﬁcit in these individuals. In
contrast, in endurance-trained muscle, characterized by
enhanced mitochondrial content and oxidative capacity,
this basal ﬂux is unchanged (78). Feasibility studies in
human visual cortex (79) and, more recently, liver (80)
also have been demonstrated. It is worth noting that high
signal/noise spectra are required to accurately estimate
the MT effect and that if the observed metabolite is in-
volved in multiple exchange reactions more complex
kinetic models and multiple-site MT methods are re-
quired (e.g., to measure ATP utilization). Finally, MT
techniques estimate the total ﬂux from all cellular con-
tributions to a speciﬁc reaction, including futile cycling.
These effects may lead to overestimation of the absolute
FIG. 5. Unidirectional ﬂuxes attributed to chemical exchange can be measured using MT techniques. Application of
31P saturation-transfer MRS in
muscle: frequency-selective irradiation of the gATP peak causes reductions in the magnitude of the PCr and Pi peaks as a result of PCr ⇆ ATP (CK)
and Pi ⇆ ATP (ATP synthesis/hydrolysis) exchange, respectively.
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terpretation of ﬂuxes in liver, where the contributions of
nonoxidative ATP generation and glycolytic enzyme cycling
may be considerable.
Metabolic reaction rates by tracer kinetics. Rates of
metabolic reactions also can be estimated by administer-
ing an MR-visible tracer and monitoring its rate of in-
corporation into tissue metabolites.
13C-MRS is ideal for
such studies because the relative lack of background sig-
nal attributed to the low natural abundance of
13C leads
to dramatic signal increases on metabolite
13C-enrichment
(Fig. 6). Furthermore, a wide range of metabolic products
can be monitored and both positional and isotopic en-
richment data can be determined, which offers a signiﬁcant
advantage over mass spectrometry. The simplest labeling
strategies monitor the accumulation of tracer into macro-
nutrient pools. Glycogen synthesis can be readily detected
in muscle and liver using labeled glucose, and insulin-
stimulated muscle glycogen synthesis has been found to be
decreased in type 2 diabetes (82). Similarly, postprandial
liver glycogen synthesis is decreased in type 2 diabetic
patients, accompanied by impaired suppression of endog-
enous glucose production (83). Patients with poorly con-
trolled type 1 diabetes also have impaired postprandial
hepatic glycogen synthesis (84). Ingestion of
13C-labeled
fatty acids allows postprandial fat storage in liver and
muscle to be determined, and both were found to be ele-
vated in type 2 diabetes (85). More complex pulse-chase
experiments (tracer administration followed by nonlabeled
washout) enable metabolite synthesis and degradation
(e.g., of liver glycogen) to be concurrently monitored. This
style of study has surprisingly demonstrated that glycogen
turnover occurs in liver in both fed and fasting states (86)
and in muscle during steady-state exercise (87). Infusion
of multiple
13C-labeled tracers has permitted the relative
contributions of different glucose sources to liver glycogen
repletion to be determined under fed and fasting con-
ditions (70).
Sophisticated computer-modeling techniques enable more
complex metabolic reaction schemes to be assessed. Rates
of oxidation via the tricarboxylic acid (TCA) cycle can be
estimated in muscle by using [2-
13C]acetate as a precursor
substrate and monitoring the rate of enrichment of the
muscle glutamate pool, which acts as a surrogate for the
intermediates of the TCA cycle (81). Decreased muscle
substrate oxidation was found in two insulin-resistant
cohorts of subjects (healthy older adults [77] and offspring
of type 2 diabetic patients [88]), demonstrating an associa-
tion between peripheral mitochondrial function and insulin
sensitivity. Conversely, increased substrate oxidation rates
have been observed in endurance-trained individuals (78).
Using [1-
13C]glucose as a substrate, multiple reaction
rates can be measured in brain, including the TCA cycle
ﬂux, a-ketogutarate/glutamate exchange, and a unique
metabolic parameter, the rate of excitatory neurotrans-
mitter (glutamate/glutamine) cycling between neuron and
astrocyte (89,90). Glial contributions to these cerebral
metabolic rates can be estimated with [2-
13C]acetate as the
metabolic precursor because of the preferential uptake by
astrocytes (91). With multivoxel data acquisition plus
segmentation analyses, gray- and white-matter compart-
mentation also can be resolved (92). Signiﬁcant increases
in TCA cycle oxidation rates have been observed in the
visual cortex in response to visual stimulation using direct
(93) and indirect (94) techniques to measure
13C isotopic
labeling. In contrast, neurotransmitter cycling, TCA cycle
ﬂux, and glucose oxidation were found to be decreased in
Alzheimer’s disease (95) and healthy aging (96). Abnor-
malities in brain glucose metabolism also have been ob-
served in other mitochondrial and metabolic disorders
(97). More recently, plasma lactate has emerged as a sig-
niﬁcant substrate source for brain metabolism (98).
FIG. 6. Reaction rates can be assessed using
13C tracer kinetics. In the brain, intravenous infusion of 1-
13C glucose leads to positional enrichment of
several cerebral metabolites (A), including glutamate (Glu), glutamine (Gln), aspartate (Asp), and GABA. Metabolic modeling of the timecourses of
enrichment (B)( ●,C 4-Glu; ○,C 4-Gln; ▲,C 2-GABA) yields estimated reaction rates (e.g., TCA cycle ﬂux, neurotransmitter cycling).
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One of the most powerful aspects of using MRS to study
metabolism in vivo is that multiple independent parame-
ters of metabolic function can be assessed across a range
of tissues. This capability offers a unique ability to explore
the mechanistic basis for the pathogenesis of metabolic
diseases and/or syndromes. MRS studies were a key factor
in elucidating the role of glucose transport in the mech-
anism of muscle insulin resistance in type 2 diabetes.
Insulin-stimulated rates of muscle glycogen synthesis (82),
measured by
13C-MRS, were found to be attenuated in
type 2 diabetes. Crucially,
31P-MRS studies demonstrated
that there also was a blunted increase in the intracellular
concentration of glucose-6-phosphate in diabetic muscle,
consistent with impaired glucose transport/phosphoryla-
tion activity, rather than a defect in glycogen synthase
activity (99).
Using a multinuclear approach, a relationship between
peripheral lipid deposition, muscle bioenergetics, and in-
sulin resistance also has been demonstrated. In two cohorts
of insulin-resistant subjects (76,77,88), the accumulation
of IMCL (and IHL in [76]), measured by localized
1H-MRS,
was associated with decreases in substrate oxidation (TCA




transfer MRS, respectively. These studies suggest that a
decline in basal mitochondrial activity, corroborated using
two independent MRS biomarkers of mitochondrial me-
tabolism, may play a role in the pathogenesis of peripheral
insulin resistance and the development of type 2 diabetes.
More recently, postprandial macronutrient storage in mus-
cle and liver in response to a carbohydrate meal has been
examined using
1H-MRS to measure lipid accumulation and
13C-MRS to assess glycogen synthesis (100). Muscle insulin
resistance alters the partitioning of carbohydrate away from
muscle glycogen synthesis and toward hepatic lipogenesis.
Interleaved
31P/
1H-MRS techniques allow muscle HEP
metabolism and myoglobin deoxygenation to be assessed
simultaneously during exercise or ischemia (101) and have
revealed complex interactions between vascular function,
intracellular oxygenation, and mitochondrial function in
elite athletes (102).
FUTURE DIRECTIONS FOR IN VIVO MRS
There is continuous development of novel MRS hardware,
pulses, sequences, and techniques to improve the in-
vestigation of human metabolism in vivo. These occur in
concert with a continual shift toward higher magnetic ﬁeld
strengths, which is accompanied by increased signal,
wider spectral bandwidth, and enhanced spectral resolu-
tion. However, elevated power requirements at higher ﬁelds
may lead to excessive localized power deposition, particu-
larly for high-duty cycle sequences and those involving
decoupling. The increased acoustic noise and space
conﬁnement of these systems may also impact subject
tolerance. In this section, we highlight a few areas of
development that already are generating signiﬁcant interest.
Functional and metabolic heterogeneity is apparent not
just between organs but also within a single tissue. Muscle
HEP content is dependent on ﬁber type (24), and varia-
tions in IMCL distribution (103,104) and Pi → ATP ﬂux
(105) have been observed in different muscle of the calf.
Differences in metabolite content and reaction rates are
also apparent between regions of the brain and between
gray matter, white matter, and cerebrospinal ﬂuid (92,106).
To robustly investigate metabolism in vivo, localized or
spatially mapped versions of many of the techniques men-
tioned in this article are required. Spectroscopic imaging
(SI) methods, which obtain MR spectra on a point-by-point
basis across an entire region of interest, offer an attractive
methodology by which this can be accomplished (Fig. 7),
and certain applications already have begun to beneﬁtf r o m
this approach (104,106–108). The recent development of
multichannel detection coils augments the SI approach,
concomitantly enhancing spatial coverage and decreasing
scan time.
Adipose tissue has been studied in a limited manner
with MRS but suffers from severe spectral broadening
as a result of the short T2 relaxation times of lipid. How-
ever, the metabolic signiﬁcance of regional differences in
glucose and fat metabolism between visceral and sub-
cutaneous fat compartments, and recent studies demon-
strating the existence of subclavicular brown fat in humans,
is beginning to spur MRS investigation of these tissues.
MR methodology lacks a direct technique to investigate
oxygen metabolism in vivo. Recently,
17O-MRS has been
implemented in animal models to measure cerebral blood
ﬂow and the metabolic rate of oxygen consumption during
17O2 inhalation. Cerebral oxygen consumption was found
to increase in the visual cortex with visual stimulation and
agreed well with
31P-MRS–determined rates of ATP syn-
thesis (109), suggesting that this technique could success-
fully be translated to human research.
Despite its vast potential,
13C-MRS is inherently limited
by low signal/noise and a broad chemical shift range. Two
approaches that enhance the sensitivity of
13C measure-
ments may transform its applicability to metabolic studies.
Proton-observe/carbon-edited (POCE) techniques acquire
1H-spectra but “edit” the spectrum to select protons coupled
to
13C nuclei (Fig. 8). Using this method,
13C-enrichment
data can be obtained with the superior localization accu-
racy and enhanced sensitivity of
1H-MRS. In vivo, the ap-
plication of POCE has been restricted by the relatively
narrow bandwidth and spectral resolution of
1H-MRS, but
the availability of high-ﬁeld systems may overcome this
restriction, providing high-quality shimming routines ensure
sufﬁcient spectral resolution (110). Hyperpolarization fa-
vorably alters the Boltzmann distribution of
13Cs p i n si n
a target molecule, increasing sensitivity by several orders
of magnitude, such that hyperpolarized
13C-tracers can be
observed with a single scan. Current applications are lim-
ited because of the requirement for specialized equipment,
FIG. 7. Magnetic resonance spectroscopic imaging (MRSI) techniques
enable the acquisition of spectral data on a point-by-point basis across
a region of interest. Muscle
1H-MRSI reveals distinct differences in lipid
content between bone marrow (voxel A) and two different locations in
the soleus (voxels B and C).
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tremely short lifetimes of hyperpolarized
13C. Nonetheless,
in vivo studies have been performed in animal models to
investigate the rapid metabolic ﬂuxes of pyruvate (111) and
lactate (112). Broader metabolic applications are yet to be
developed, but this technique may potentially revolutionize
in vivo
13C-MRS.
Chemical-exchange-saturation-transfer (CEST) is an MT
method that examines generic exchange between labile
metabolite protons and bulk water. Although primarily
implemented as an MRI-based technique that provides
exchange-based contrast, several intriguing metabolic
applications are emerging. These include pH imaging (e.g.,
to discern tumors), glucose sensing, and imaging of glyco-
gen distribution. CEST may also have applications as a
biomarker of gene expression detecting
1H exchange ﬂuxes
that are catalyzed by a speciﬁc enzyme, a gene delivery
agent or by the RNA polymer itself. The review by Zhou and
van Zijl (113) provides a comprehensive analysis of CEST
techniques.
To date, the capabilities of MRS primarily have been
exploited in research where it has advanced our un-
derstanding of the mechanisms behind fundamental met-
abolic processes and the pathogenesis of disease. More
widespread availability and the translation of MRS into
a practical clinical diagnostic tool has been curtailed by
several factors: dedicated spectroscopy systems and spe-
cialized expertise have been required leading to high costs,
scan times are relatively long, and many individuals are
excluded from undergoing MR scans (e.g., those with
implanted metal, pacemakers, or claustrophobia). How-
ever, the new generation of high-ﬁeld (3 Tesla, and above)
clinical MRI scanners can be equipped with spectroscopy
capabilities, and this, combined with the advent of robust
automated processing routines and rapid data-acquisition
techniques, offers the scope for more widespread appli-
cation of MRS techniques to human research and the po-
tential for translation into a clinically useful methodology.
In vivo MRS promises to be a key technique contributing to
the investigation of human metabolism in the 21st century.
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